Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeOwlstone MedicalOwlstone Medical to Join EU-Funded EPHOR Consortium

Owlstone Medical to Join EU-Funded EPHOR Consortium

Owlstone Medical today announced it has joined the EU-funded Exposome Project for Health and Occupational Research (EPHOR). The consortium aims to further elucidate the complex relationships between environment and disease by developing the concept of the ‘working-life exposome’, which takes into account all occupational and related non-occupational exposures (e.g. lifestyle) throughout the lifespan of an individual. Owlstone Medical will receive funding from the project to provide Breath Biopsy Collection Stations and Kits for the collection of breath samples and will perform analysis on samples received.

EPHOR brings together an exceptional consortium of exposure, health and data scientists, and technology partners in order to develop knowledge, methods, and tools to characterize the working-life exposome at a far deeper level than has previously been attempted. The consortium will combine large-scale pooling of existing data (>40 cohorts; ~21 million people) and systematically look at a wide range of exposures and diseases. The information generated will be made available via a ‘working-life toolbox’, allowing scientists to use and enhance the data, methods, and models currently in use in exposome research.

Simultaneously, new data will be generated, particularly in the area of respiratory disease, by comparing the exposome and health status of workers in a range of industries with that of the general population. Through this effort, in combination with similar data obtained from blood, non-invasive exposome biomarkers on breath will be developed to enable monitoring of lung health and the burden of exposure.

Exposures in the workplace can lead to many forms of disease including cancer, cardiovascular, and respiratory disease, and the total global burden of disease caused by occupational exposures is estimated at 5-7%, similar to the burden resulting from urban air pollution or obesity. Ensuring a healthy work environment is, therefore, an important goal for government and industry, however, such policies are currently limited to what can be concluded from existing scientific evidence.

Billy Boyle, co-founder and CEO at Owlstone Medical, said: “Environmental exposures, including those from the workplace, are known to have a tremendous impact on the start and progression of disease. The EPHOR project promises to directly address this problem, contributing to reducing the burden of workplace exposure on healthcare systems and helping to improve the general health and wellbeing of the population.” He continued, “The EPHOR project, similar to the recently announced 3TR IMI2 Immunology Project1, demonstrates that Breath Biopsy is becoming a standard component of disease research and biomarker discovery and that Owlstone Medical is the clear leader in the ability to provide this capability.”

Additional information on the EPHOR project will be available at www.ephor-project.eu from January 2020.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy